Phase 1/2 Clinical Trial of PR006 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)

Condition:   Frontotemporal Dementia Intervention:   Biological: PR006 Sponsor:   Prevail Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials